Evaluation of Enzyme Producing K. Pneumoniae and Their Susceptibility to Other Anti-Biotics


Authors : Purabi Saha; Anubhav Dubey; Dr. Sanjay Kumar; Roshan Kumar

Volume/Issue : Volume 7 - 2022, Issue 5 - May

Google Scholar : https://bit.ly/3IIfn9N

Scribd : https://bit.ly/3x7J0hX

DOI : https://doi.org/10.5281/zenodo.6604903

Antimicrobial-resistant microbes are now infecting doctors, veterinarians, and other infection control specialists. Material & Method: Collection of samples and isolation of K. pneumoniae, Anti-microbial Susceptibility pattern, Hodge's modified test, Extraction of the bla KPC2 gene's DNA Result & Discussion: More than half of the isolates were resistant to both imipenem and meropenem, with four being just resistant to imipenem. Among the 38 carbapenem resistant isolates, 71% had imipenem MICs above CLSI norms, whereas the remaining 79.9% were intermediately resistant. The MIC50 and MIC90 were 0.19-32, 4 and 16 g/ml, respectively (21.05 percent ). Eight of the isolates had MHT. The blaKPC-2 imipenem MIC is 4-32 g/ml. Neither colistin nor co-trimaxazole resistant BlaKPC-2 isolates. Conclusion: Our institution found blaKPC-2 to be a carbapenem resistant K. pneumoniae pathway. Results demonstrated imipenem disc diffusion can quickly identify these isolates. These illnesses and their associated drug resistance demand infection control and antibiotic stewardship measures.

Keywords : K. Pneumonia, gene, DNA, Anti-microbial.

CALL FOR PAPERS


Paper Submission Last Date
29 - February - 2024

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe